|Bid||27.00 x 1100|
|Ask||27.15 x 1400|
|Day's Range||25.46 - 27.11|
|52 Week Range||23.08 - 101.70|
|Beta (5Y Monthly)||0.93|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 20, 2023 - Feb 24, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||32.84|
ARK ETF Founder Cathie Wood joins Yahoo Finance Live for a wide-ranging interview on the state of the crypto market, Elon Musk, Fed policy, Teladoc, and more.
Three good examples are Teladoc Health (NYSE: TDOC), Nike (NYSE: NKE), and Crispr Therapeutics (NASDAQ: CRSP). Two billion-dollar noncash goodwill impairment charges hurt Teladoc's earnings this year -- and investor sentiment. More than half of Fortune 500 companies are clients.
Many would argue that searching for 100-baggers -- stocks that return $100 for every $1 invested -- is as likely as winning the lottery. That exorbitant price tag has wreaked havoc with the company's financials -- especially its profitability.